These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11421823)

  • 1. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children.
    Brix-Christensen V
    Acta Anaesthesiol Scand; 2001 Jul; 45(6):671-9. PubMed ID: 11421823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of neutrophil in inflammatory response after cardiac surgery with cardiopulmonary bypass].
    Paśnik J
    Wiad Lek; 2007; 60(3-4):171-7. PubMed ID: 17726872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to transient systemic immune suppression.
    Tárnok A; Schneider P
    Shock; 2001; 16 Suppl 1():24-32. PubMed ID: 11770029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass.
    Tárnok A; Hambsch J; Emmrich F; Sack U; van Son J; Bellinghausen W; Borte M; Schneider P
    Pediatr Cardiol; 1999; 20(2):113-25. PubMed ID: 9986887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alterations of metalloproteinases and their inhibitors concentrations in peripheral blood in children with congenital heart disease undergoing cardiac surgery with cardiopulmonary bypass].
    Paśnik J; Cywińska-Bernas A; Moll J; Moll J; Sysa A; Zeman K
    Przegl Lek; 2009; 66(7):359-64. PubMed ID: 20043576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery.
    Pągowska-Klimek I; Świerzko AS; Michalski M; Głowacka E; Szala-Poździej A; Sokołowska A; Moll M; Krajewski WR; Romak J; Cedzyński M
    Clin Exp Immunol; 2016 May; 184(2):257-63. PubMed ID: 26703090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of cardiopulmonary bypass: what is the reality?
    Murphy GJ; Angelini GD
    J Card Surg; 2004; 19(6):481-8. PubMed ID: 15548178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies.
    Wan S; LeClerc JL; Vincent JL
    Chest; 1997 Sep; 112(3):676-92. PubMed ID: 9315800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperoxic condition promotes an inflammatory response during cardiopulmonary bypass in a rat model.
    Fujii Y; Shirai M; Tsuchimochi H; Pearson JT; Takewa Y; Tatsumi E; Taenaka Y
    Artif Organs; 2013 Dec; 37(12):1034-40. PubMed ID: 23865518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation and cardiac surgery: an update.
    Asimakopoulos G
    Perfusion; 2001 Sep; 16(5):353-60. PubMed ID: 11565890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The systemic inflammatory response to cardiopulmonary bypass.
    Pintar T; Collard CD
    Anesthesiol Clin North Am; 2003 Sep; 21(3):453-64. PubMed ID: 14562560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil activation during cardiopulmonary bypass in paediatric and adult patients.
    Larson DF; Bowers M; Schechner HW
    Perfusion; 1996 Jan; 11(1):21-7. PubMed ID: 8904323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
    Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
    Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of the novel leukocyte removal filter in cardiopulmonary bypass.
    Fujii Y
    Expert Rev Med Devices; 2016; 13(1):5-14. PubMed ID: 26613267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiopulmonary bypass elicits a pro- and anti-inflammatory cytokine response and impaired neutrophil chemotaxis in neonatal pigs.
    Brix-Christensen V; Petersen TK; Ravn HB; Hjortdal VE; Andersen NT; Tønnesen E
    Acta Anaesthesiol Scand; 2001 Apr; 45(4):407-13. PubMed ID: 11300377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass.
    Chello M; Mastroroberto P; Quirino A; Cuda G; Perticone F; Cirillo F; Covino E
    Ann Thorac Surg; 2002 Jan; 73(1):123-9; discussion 129-30. PubMed ID: 11833998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.
    Mojcik CF; Levy JH
    Ann Thorac Surg; 2001 Feb; 71(2):745-54. PubMed ID: 11235755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.
    Paparella D; Yau TM; Young E
    Eur J Cardiothorac Surg; 2002 Feb; 21(2):232-44. PubMed ID: 11825729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimizing systemic inflammation during cardiopulmonary bypass in the pediatric population.
    Durandy Y
    Artif Organs; 2014 Jan; 38(1):11-8. PubMed ID: 24392866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.